Matches in Wikidata for { <http://www.wikidata.org/entity/Q93328935> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q93328935 description "clinical trial" @default.
- Q93328935 description "ensayo clínico" @default.
- Q93328935 description "ensayu clínicu" @default.
- Q93328935 description "klinisch onderzoek" @default.
- Q93328935 description "клінічне випробування" @default.
- Q93328935 description "临床试验" @default.
- Q93328935 name "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant" @default.
- Q93328935 name "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS" @default.
- Q93328935 type Item @default.
- Q93328935 label "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant" @default.
- Q93328935 label "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS" @default.
- Q93328935 prefLabel "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant" @default.
- Q93328935 prefLabel "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS" @default.
- Q93328935 P1132 Q93328935-57F472DF-4CB0-4CF7-B1F6-05E34AAC4883 @default.
- Q93328935 P1476 Q93328935-4EE7701E-3C90-47A9-995C-3C886689AFF5 @default.
- Q93328935 P17 Q93328935-C24FFBB2-46B9-4C50-B41A-1D4851BC2816 @default.
- Q93328935 P2899 Q93328935-13B5E618-14AB-45C6-856F-66D7260F17DD @default.
- Q93328935 P3098 Q93328935-0125EEC6-184A-4B61-B9FE-0CED81F9F477 @default.
- Q93328935 P31 Q93328935-B373549F-3543-4BF6-8C0E-E803653006D0 @default.
- Q93328935 P4135 Q93328935-0BB6B193-D4CC-42A2-A1B2-ED7E26EF0D14 @default.
- Q93328935 P4844 Q93328935-84CD1817-5CC9-4956-9D3A-CE62969936DB @default.
- Q93328935 P580 Q93328935-A8B073E8-49F7-48AF-A2A4-1528E95071D5 @default.
- Q93328935 P582 Q93328935-A5121EC5-CC88-4EDC-B6E1-46CAD7C0A8B7 @default.
- Q93328935 P6099 Q93328935-D32B927C-353B-450D-9DA6-09F3E6605B9E @default.
- Q93328935 P8005 Q93328935-21B37223-94EA-45CF-B329-89350B28A7A7 @default.
- Q93328935 P8363 Q93328935-7B60F505-3A4F-47A7-8EF0-71C0253F4B19 @default.
- Q93328935 P921 Q93328935-1F686D9C-DF78-4093-B1EF-DD0E532EE4AC @default.
- Q93328935 P1132 "+131" @default.
- Q93328935 P1476 "A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects" @default.
- Q93328935 P17 Q408 @default.
- Q93328935 P2899 "+18" @default.
- Q93328935 P3098 "NCT04368988" @default.
- Q93328935 P31 Q30612 @default.
- Q93328935 P4135 "+59" @default.
- Q93328935 P4844 Q97154235 @default.
- Q93328935 P580 "2020-05-15T00:00:00Z" @default.
- Q93328935 P582 "2020-12-31T00:00:00Z" @default.
- Q93328935 P6099 Q5452194 @default.
- Q93328935 P8005 Q76649708 @default.
- Q93328935 P8363 Q78089383 @default.
- Q93328935 P921 Q97154235 @default.